Genetic studies show that polymorphisms in MMP-1 and MMP-3 are linked to distinct clinical phenotypes: for example, the MMP-1 1G/1G genotype correlates with interstitial lung disease, while the MMP-3 5A/5A variant is associated with anti-topoisomerase antibodies [32]. This evidence concerns the gene MMP1 and interstitial lung disease.